End-of-life care for people with likely terminal cancer can be quite variable, and may have indicators of poor care quality as well as running up health spending. A new study attempts to identify reasons for variation and the extent to which it is linked with multiple morbidity. (J. Geriatric Oncology Article) The authors used data from 1991 to 2008 from surveys and Medicare fee-for-service claims to identify patients who had terminal cancer and multiple chronic diseases and functional limitations. They studied use of hospice, death in hospital, use of hospital or ER in the last month of life, and use of aggressive cancer treatment. About 60% of all the patients in the study had a combination of chronic conditions, functional limitations and geriatric syndromes. Older patients were less likely to receive cancer treatment near the end-of-life. People with higher education and income were more likely to receive such treatment. There were no significant differences in race or ethnicity. Admission to a hospital or an ER was lower in older patients, but higher among African-Americans and use of hospice was lower among that group. Therefor, African-Americans were more likely to die in the hospital. Income and education had a U-shaped association with in-hospital death. Age and marital sex were not associated strongly with any of the outcomes. High morbidity was not associated with any outcome, but more functional limitations and presence of geriatric syndrome made it less likely that cancer treatment would be received. From this study, it would appear that there generally are not strong associations with many social determinants and end-of-life care, nor with many general health status issues. This suggests that using these factors as a basis for intervention to ensure more rational use of end-of-life care will be difficult.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
What do you get when you combine a company with a commodity business model, that out of desperation massively overpays for another company that has a commodity business model? $10...
July 27, 2022
The “stupid” model for health care venture capital investing is alive and well. Everside health, which operates primary care clinics and has grown by acquiring other failing health care businesses,...
July 26, 2022
Apparently not even a cute name can save you if you have a stupid business. I constantly bemoan the mis-application of capital and health care is Exhibit A. Olive, another...
July 26, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace